Aratana Seeks Approval of Osteoarthritis Therapy
February 18, 2016
Aratana Therapeutics Inc. is asking for U.S. and European approvals of a treatment for osteoarthritis pain and inflammation in dogs. Prompt action from the U.S. Food and Drug Administration’s Center for Veterinary Medicine could lead to Galliprant (grapiprant tablets) being made available to veterinarians this fall, according to the Leawood, Kan., company. An administrative New… Continue reading...